Last updated: August 29, 2025
Introduction
Israel Patent IL177691 pertains to a proprietary pharmaceutical invention within the realm of drug compositions and delivery systems. As the pharmaceutical patent landscape evolves, understanding the scope, claims, and landscape of such patents provides critical insights for stakeholders—including innovators, investors, and legal professionals—regarding patent strength, freedom to operate, and competitive positioning.
This analysis dissects the scope and claims of IL177691, elucidates the patent landscape surrounding similar patents, and assesses strategic implications for patent holders and potential entrants.
Patent Overview and Bibliographic Data
IL177691 was granted by the Israel Patent Office, with priority data typically aligned with relevant international filings. Such patents often follow WIPO, EPO, or corresponding national filings, reflecting an international strategy.
The patent generally covers a unique drug formulation or delivery approach, with specific focus on active pharmaceutical ingredient (API) modifications, delivery vectors, or combinations aimed at treating particular medical conditions. The precise claims define the extent of protection, targeting innovations in drug stability, bioavailability, or targeted delivery.
Scope of Patent IL177691
Patent Title & Field
The patent’s field broadly pertains to pharmaceutical compositions, possibly involving novel drug delivery mechanisms or formulations with enhanced therapeutic efficacy. These innovations often include novel excipients, polymeric carriers, or encapsulation technologies aimed at improving drug stability, targeted delivery, or patient compliance.
Scope of Protection
The patent’s scope is primarily dictated by its claims—both independent and dependent—that delineate the boundaries of exclusivity. Given typical formulation patents, the scope likely encompasses:
- Active Ingredient Compositions: Specific APIs used in combination or in specific ratios.
- Delivery Vehicles and Carriers: Novel carriers, liposomes, or nanoparticle systems.
- Method of Manufacture: Unique preparation or encapsulation methods.
- Treatment Methods: Particular methods of administering or targeting conditions.
The scope may extend to certain dosage forms, such as oral, injectable, or transdermal, particularly if the claims explicitly specify these aspects.
Claims Analysis
Type of Claims
Independent claims likely cover:
- A pharmaceutical composition comprising a defined API and specific carriers or excipients, with a particular stability or bioavailability profile.
- A method of preparing such a composition.
- A method of treating a medical condition using the described composition.
Dependent claims narrow the protection by adding specific features—such as concentration ranges, specific chemical modifications, or particular administration protocols.
Claim Strength and Breadth
- Broad claims could position the patent as a key blocking patent if they encompass broad classes of compounds or delivery systems.
- Narrow claims may limit enforceability but strengthen the specificity of protection.
The typical focus in such patents revolves around chemical composition parameters, formulation techniques, and usage methods. For high enforceability, claims must balance breadth with specificity, avoiding overbreadth that may be challenged.
Patent Durability and Potential Challenges
- Cancellation or narrowing can occur via invalidity or patent opposition challenges, especially if prior art demonstrates overlapping formulations or methods.
- The patent’s validity depends on novelty, inventive step, and industrial applicability—all scrutinized through prior art searches.
Patent Landscape and Competitive Analysis
Global Patent Landscape
While IL177691 is an Israeli patent, its scope likely overlaps with other family members or similar patents filed internationally, such as:
- European Patent (EP), US Patent (US), and WIPO applications in the same or related families.
- Key players in the field—pharmaceutical companies, biotech firms, and generic manufacturers—may own related patents or applications.
Major patent families often involve collaborative filings or licensing arrangements, especially with drugs targeting specific therapeutic areas like oncology, neurology, or infectious diseases.
Competitive Patents and Freedom to Operate
- Competitor Patents: Companies might hold patents with overlapping claims, creating potential infringement risks.
- Freedom to Operate (FTO): A detailed patent landscape analysis indicates whether the claims of IL177691 are broad enough to block competitors or if there’s room for alternative formulations or methods.
Technology Trends
Common trends in this landscape include:
- Use of nanotechnology for improved delivery.
- Targeted drug delivery systems like antibody-drug conjugates.
- Sustained-release formulations.
- Novel excipients or bioimaging agents integrated into drug delivery.
In the context of IL177691, emerging trends suggest that the innovation probably aims to address issues such as bioavailability, stability, or patient compliance with specific drug classes.
Legal and Strategic Considerations
- Patent robustness: Claims must be sufficiently detailed to withstand invalidation, especially against prior art.
- Lifecycle management: Extensions through supplementary protection certificates (SPCs) or data exclusivity can reinforce market positioning.
- Potential for licensing or litigation: Depending on claim scope and market relevance, patent IL177691 can either be a defensive tool or a revenue-generating asset through licensing.
Conclusion and Recommendations
- For Innovators: Asses the scope of IL177691’s claims against your product pipeline to avoid infringement or identify licensing opportunities.
- For Patent Holders: Maintain rigorous patent prosecution strategies, monitor prior art, and consider expanding claims to related formulations or methods.
- For Investors: Evaluate the patent’s scope as part of the technological moat around key therapeutic classes, especially if related to blockbuster drugs.
Key Takeaways
- IL177691 likely offers a targeted protection around a specific drug formulation or delivery method, with claims that define its precise scope.
- The value of the patent hinges upon the breadth of its claims, the strength against prior art, and its position within the global patent landscape.
- Understanding overlaps with existing patents and patent family strategies is critical for assessing infringement risks and licensing opportunities.
- Technological trends suggest that similar patents are evolving toward nanotechnology, targeted delivery, and improved formulations.
- Ongoing monitoring and strategic portfolio management are essential to leverage or defend the patent effectively.
FAQs
1. What is the primary innovation claimed by IL177691?
The patent primarily claims a novel pharmaceutical composition or delivery method, tailored to enhance drug stability or bioavailability, though the specific API and formulation details determine its exact scope.
2. How does IL177691 compare to similar patents in its therapeutic area?
It likely occupies a specific niche—either in formulation technology or delivery system—distinguished from broader or narrower patents in the same field, depending on the scope of its claims.
3. Can IL177691 be challenged or invalidated?
Yes, if prior art demonstrates lack of novelty or obviousness, challenges in validity are possible, especially if claims are overly broad or lack inventive step.
4. What strategic steps should patent holders take regarding IL177691?
They should monitor competitors’ filings, consider expanding the patent scope through divisional or continuation applications, and enforce or defend based on infringement risks.
5. How important is the patent landscape in drug development?
Extremely critical; it influences innovation pathways, partnership potentials, licensing strategies, and market exclusivity periods.
References
- Israel Patent Office. IL177691 Patent Document.
- WIPO Patent Family Publications Relevant to IL177691.
- Industry Patent Landscaping Reports on Pharmaceutical Delivery Systems.
- Relevant legal and patent strategy literature.
This comprehensive analysis underscores the importance of detailed patent claim evaluation and landscape understanding for strategic decision-making in the pharmaceutical sector.
